Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience.


Sezione di Gastroenterologia & Epatologia, Dipartimento Biomedico di Medicina Interna e Specialistica, Università di Palermo, Palermo, Italy. Electronic address: [Email]


In 2017 the Italian Drug Agency (Agenzia Italiana del Farmaco, AIFA) revised the criteria for access to therapy for patients with chronic hepatitis C as part of a three-year plan to eradicate HCV. We conducted a Delphi study to determine strategies to identify and treat patients with HCV and to develop through a shared pathway, a model to manage patient referral and optimize prescription center capacity with the overall aim of increasing access to therapy.


Delphi method,Hepatitis C virus,direct-acting antivirals,disease eradication,

OUR Recent Articles